Showing results (171-180 of 192) with videos related to
Sort By:
Pageof 20
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 18, 2017
Acute impact of conventional and eccentric cycling on platelet and vascular function in patients with chronic heart failureAndrew Haynes, Matthew D Linden, Lauren C Chasland, et al.Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary interventionM I Furman, L A Krueger, M D Linden, et al.Archives of Pathology & Laboratory Medicine|June 3, 2006
The CD117 immunohistochemistry tissue microarray survey for quality assurance and interlaboratory comparison: a College of American Pathologists Cell Markers Committee StudyDavid M Dorfman, Marilyn M Bui, Raymond R Tubbs, et al.Blood|February 2, 2012
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activationBethan Psaila, James B Bussel, Matthew D Linden, et al.Journal of Thrombosis and Haemostasis : JTH|November 20, 2009
Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosisK Przyklenk, A L Frelinger, M D Linden, et al.Cytometry|January 1, 1991
Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometryG H Segal, M G Edinger, M Owen, et al.Journal of Thrombosis and Haemostasis : JTH|September 17, 2011
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopeniaB Psaila, J B Bussel, A L Frelinger, et al.Journal of Thrombosis and Haemostasis : JTH|September 28, 2006
Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'A D Michelson, M D Linden, M I Furman, et al.Blood|February 12, 2005
Platelet activation in cystic fibrosisBrian P O'Sullivan, Matthew D Linden, Andrew L Frelinger, et al.Thrombosis and Haemostasis|June 29, 2007
The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirinAndrew L Frelinger, Joseph A Jakubowski, Youfu Li, et al.Pageof 20